Cargando…
Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer
Muscle-invasive bladder cancer (MIBC) is associated with low survival and high recurrence rates even in cases in which patients receive systemic treatments, such as surgery and chemotherapy. Here, we found that a naturally existing alphavirus, namely, M1, selectively kills bladder cancer cells but n...
Autores principales: | Hu, Cheng, Liu, Ying, Lin, Yuan, Liang, Jian-Kai, Zhong, Wen-Wen, Li, Ke, Huang, Wen-Tao, Wang, De-Juan, Yan, Guang-Mei, Zhu, Wen-Bo, Qiu, Jian-Guang, Gao, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833719/ https://www.ncbi.nlm.nih.gov/pubmed/29449555 http://dx.doi.org/10.1038/s41419-018-0325-3 |
Ejemplares similares
-
Suppression of CCDC6 sensitizes tumor to oncolytic virus M1
por: Liu, Ying, et al.
Publicado: (2020) -
Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity
por: Ying, Liu, et al.
Publicado: (2017) -
Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade
por: Liu, Yang, et al.
Publicado: (2020) -
Influence of polyethylene glycol coating on biodistribution and toxicity of nanoscale graphene oxide in mice after intravenous injection
por: Li, Bo, et al.
Publicado: (2014) -
The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer
por: Chen, Jian-Xin, et al.
Publicado: (2023)